Drug intelligence / Profile preview

Yizhi Ningshen Liquid

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Yizhi Ningshen Liquid is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of attention-deficit/hyperactivity disorder (ADHD) and related syndromes characterized by symptoms such as restlessness, inattention, and hyperactivity. The prescription is designed to "soothe the nerves, nourish the mind, and resuscitate," according to TCM theory. It is typically administered as an oral liquid. The exact herbal composition may vary but generally includes ingredients aimed at calming the spirit and supporting cognitive function. Its mechanism of action is based on traditional Chinese medical principles rather than modern pharmacological targets[1].

Brand names: Yizhi Ningshen Liquid
Other names: Yizhiningshen益智宁神口服液 (Chinese name)

Beyond the preview

Go deeper on Yizhi Ningshen Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yizhi Ningshen Liquid.

Explore the full profile